Antonio Fojo and Neeta Amin Selected as Keynotes at CHI’s Accelerating Proof-of Concept Conference

Aug. 11, 2011 - PRLog -- Antonio Tito Fojo, M.D., Ph.D., Head, Experimental Therapeutics Section, NCI, NIH, kicks off this conference at 1:30 p.m with his talk,  How to Get and Learn so Much More from Data Captured in Clinical Trials of Cancer Therapeutics. Then at 2:15, Neeta Amin, Pharm D., Director, CVMED Research Unit, Pfizer, will discuss Delivery of a Robust Phase III Ready Package with First Dose in Clinic to Last Visit in Phase II in 15 Months – Example of PF-04971729 at Pfizer.

Science, strategy, and success is the theme at CHI’s Accelerating Proof-of-Concept conference. The conference will approach proof-of-concept from multiple angles: preclinical, early development and regulatory. It will include presentations from industry leaders, commentary from global regulators and strategy discussions throughout on topics such as data analysis for decision making, surrogate endpoints, reducing attrition and more. Delegates will participate in roundtable forums on defining proof of concept, while networking with peers and industry leaders.

Cambridge Healthtech Institute (CHI) organized this conference with the assistance of its advisory board:

John Arrowsmith, Ph.D., Science Director, CMR International

Russell Linderman, Ph.D., Executive Director, Research Science & Technology PGRD, Pfizer Inc.

Terri Roberson, MT (ASCP), M.B.A., Sr. Director, Operations, Global External Research and Development, Lilly Research Laboratories, Eli Lilly and Company

For more details and to register, please visit http://www.healthtech.com/pfc. Those that register by August 26 will save up to $200.

To inquire about sponsoring and/or exhibiting, contact Carol Dinerstein, 781-972-5471, dinerstein@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com